COONEY CHARLES L 4
4 · Codiak BioSciences, Inc. · Filed Feb 21, 2023
Insider Transaction Report
Form 4
COONEY CHARLES L
Director
Transactions
- Exercise/Conversion
Common Stock
2023-02-16+8,750→ 8,750 total - Exercise/Conversion
Restricted Stock Units
2023-02-16−8,750→ 0 total→ Common Stock (8,750 underlying)
Footnotes (3)
- [F1]Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
- [F2]Each RSU represents a contingent right to receive one share of common stock.
- [F3]On February 16, 2022, the reporting person was granted 8,750 RSUs, which vested in full on February 16, 2023.